ISSN: 2155-9899
+44 1223 790975
Geraldine Cambridge
Founding director, seed investor and non-executive director in Cambridge gene editing company
Research interest in Rituximab Rituxan; Ig: Immunoglobulin; DMARD: Disease Modifying Anti-Rheumatic Drug, Hypogammaglobulinaemia; DAS28; Infections